Table 2. “ DD Protocol”: treatment scheme for multiple myeloma with liposomal daunorubicin and dexamethasone.
| Days | Drug/resting | Dose/time of administration | Route |
|---|---|---|---|
| 1 | liposomal daunorubicin dexamethasone |
25-30 mg/m2/day for 2 hours 10 mg, every 6 hours |
intravenous oral |
| 2 | liposomal daunorubicin dexamethasone |
25-30 mg/m2/day for 2 hours 10 mg, every 6 hours |
intravenous oral |
| 3 | liposomal daunorubicin dexamethasone |
25-30 mg/m2/day for 2 hours 10 mg, every 6 hours |
intravenous oral |
| 4 | liposomal daunorubicin dexamethasone |
- 10 mg, every 6 hours |
- oral |
| 5 to 8 | Resting | ||
| 9 to12 | liposomal daunorubicin dexamethasone |
- 10 mg, every 6 hours |
- oral |
| 13 to16 | Resting | ||
| 17 to 20 | liposomal daunorubicin dexamethasone |
- 10 mg, every 6 hours |
- oral |
| 21 to 30 | Resting |